Insufficient scRNA-seq data for expression of OAZ3 at single-cell level.
Insufficient scRNA-seq data for expression of OAZ3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 444.53 | 245 / 245 | 99% | 3.59 | 496 / 502 |
breast | 99% | 90.42 | 455 / 459 | 76% | 1.70 | 850 / 1118 |
thymus | 100% | 188.50 | 653 / 653 | 71% | 1.22 | 431 / 605 |
adrenal gland | 98% | 50.91 | 252 / 258 | 35% | 0.51 | 80 / 230 |
brain | 100% | 117.55 | 2636 / 2642 | 32% | 0.43 | 229 / 705 |
lung | 96% | 60.60 | 554 / 578 | 31% | 0.58 | 356 / 1155 |
skin | 97% | 42.70 | 1747 / 1809 | 18% | 0.23 | 83 / 472 |
intestine | 99% | 50.94 | 961 / 966 | 7% | 0.09 | 37 / 527 |
bladder | 90% | 37.10 | 19 / 21 | 13% | 0.22 | 68 / 504 |
esophagus | 97% | 43.66 | 1400 / 1445 | 7% | 0.13 | 12 / 183 |
kidney | 99% | 52.98 | 88 / 89 | 2% | 0.03 | 21 / 901 |
stomach | 97% | 38.31 | 348 / 359 | 4% | 0.05 | 11 / 286 |
spleen | 100% | 65.54 | 240 / 241 | 0% | 0 | 0 / 0 |
uterus | 79% | 22.82 | 135 / 170 | 20% | 0.29 | 91 / 459 |
pancreas | 95% | 41.84 | 313 / 328 | 3% | 0.04 | 6 / 178 |
adipose | 97% | 51.14 | 1163 / 1204 | 0% | 0 | 0 / 0 |
liver | 89% | 45.97 | 201 / 226 | 8% | 0.11 | 31 / 406 |
muscle | 91% | 33.69 | 728 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 82% | 25.13 | 1094 / 1335 | 0% | 0 | 0 / 0 |
heart | 62% | 16.34 | 537 / 861 | 0% | 0 | 0 / 0 |
ovary | 37% | 8.31 | 67 / 180 | 4% | 0.05 | 16 / 430 |
peripheral blood | 29% | 7.10 | 265 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_1902268 | Biological process | negative regulation of polyamine transmembrane transport |
GO_0007283 | Biological process | spermatogenesis |
GO_0090316 | Biological process | positive regulation of intracellular protein transport |
GO_0006596 | Biological process | polyamine biosynthetic process |
GO_0072562 | Cellular component | blood microparticle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008073 | Molecular function | ornithine decarboxylase inhibitor activity |
Gene name | OAZ3 |
Protein name | Ornithine decarboxylase antizyme 3 (AZ3) (ODC-Az 3) Ornithine decarboxylase antizyme 3 |
Synonyms | |
Description | FUNCTION: Ornithine decarboxylase (ODC) antizyme protein that negatively regulates ODC activity and intracellular polyamine biosynthesis and uptake in response to increased intracellular polyamine levels. Binds to ODC monomers, inhibiting the assembly of the functional ODC homodimers. Does not target the ODC monomers for degradation, which allows a protein synthesis-independent restoration of ODC activity . Stabilizes AZIN2 by interfering with its ubiquitination. Involved in the translocation of AZNI2 from ER-Golgi intermediate compartment (ERGIC) to the cytosol. Probably plays a key role in spermatogenesis by regulating the intracellular concentration of polyamines in haploid germ cells (By similarity). . |
Accessions | ENST00000635374.1 A0A0G2JH29 A0A0U1RR57 Q5SZR7 ENST00000400999 H0Y7Y4 A8MW57 ENST00000453029.2 A0A0U1RRA2 ENST00000321531.10 ENST00000582415.2 J3QLT2 ENST00000479764.7 ENST00000400999.7 [Q9UMX2-1] ENST00000635322.1 Q9UMX2 |